Volition

Volition is a leading epigenetics biomarker company, renowned for its proprietary liquid biopsy immunoassay approach to profiling nucleosomes.
​
Purchase on Scientist.com
​

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

The Latest Insights & Innovations from

Volition

Webinars
Blogs
Podcasts
​
ON DEMAND
​
Webinar

Circulating Nucleosome Quantification (Nu.Q) Technology for Monitoring Target Engagement and Adverse Events in Oncology Trials

April 29, 2024
Learn more
No items found.
No items found.
​
See it in Action

The Digital Backbone for Modern Life Sciences

Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.

​
Request a Personalized Demo